FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns pharmaceutical composition for vaccination against infection, allergy or allergic disease, autoimmune disease or cancer or tumors, contains complex of polymer carrier and carried substance, at least one protein or peptide antigen. Group of inventions also concerns kit for vaccination against infection, allergy or allergic disease, autoimmune disease or cancer or tumors; use of said pharmaceutical composition as vaccine.
EFFECT: group of inventions provides increased immune response to peptide or protein.
13 cl, 16 ex, 30 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| OBTAINING OF COMPLEXES OF NUCLEIC ACIDS AND CATIONIC COMPONENTS CROSS SEWED BY DISULFIDE BONDS INTENDED FOR TRANSFECTION AND IMMUNOSTIMULATION | 2011 |
|
RU2575603C2 |
| PRIME-BOOST MODES INVOLVING INTRODUCTION OF AT LEAST ONE MRNA STRUCTURE | 2016 |
|
RU2742993C2 |
| COMBINATION OF ANTI-CANCER RNA VACCINE AND PD-1 PATHWAY INHIBITOR AND ITS APPLICATION | 2014 |
|
RU2718988C2 |
| HYBRID CARRIERS FOR DELIVERY OF NUCLEIC ACIDS | 2017 |
|
RU2751001C2 |
| DISULPHIDE-LINKED POLYETHYLENE GLYCOL/PEPTIDE CONJUGATES FOR NUCLEIC ACID TRANSFECTION | 2010 |
|
RU2552352C2 |
| IMMUNE STIMULATING AND VACCINE COMPOSITIONS | 2011 |
|
RU2578420C2 |
| FORMULA FOR INTRODUCING RNA | 2019 |
|
RU2797147C2 |
| FUSED POLYPEPTIDES AND VACCINES | 2014 |
|
RU2699006C2 |
| CONJUGATES AND COMPOSITIONS FOR IMMUNOTHERAPY AND ANTICANCER TREATMENT | 2010 |
|
RU2597989C2 |
| COMPOSITION FOR RNA ADMINISTRATION | 2017 |
|
RU2746118C2 |
